Y-mAbs Therapeutics, Inc. (YMAB) Earnings Report - Discounting Cash Flows
YMAB
Y-mAbs Therapeutics, Inc.
YMAB (NASDAQ)
Period Ending: 2025
08-08
2025
05-13
2025
03-04
2024
11-08
2024
08-12
2024
05-07
2024
02-29
2023
11-13
2023
08-10
2023
05-08
2023
03-30
2022
11-07
2022
08-08
2022
05-09
2022
02-24
2021
11-04
2021
08-05
2021
05-06
2021
02-25
2020
11-05
2020
08-06
2020
05-07
2020
03-12
2019
11-13
2019
08-14
2019
05-10
2019
03-22
2018
11-13
2018
09-24
2018
03-31
2017
12-30
2017
09-29
2017
06-29
2017
03-30
Actual EPS -0.07 -0.12 -0.15 -0.16 -0.21 -0.15 -0.02 -0.18 -0.14 -0.15 0.03 -0.63 -0.94 -0.64 -0.85 -0.66 -0.53 0.75 -0.48 -0.82 -1.01 -0.66 -0.60 -0.70 -0.53 -0.47 -0.42 -0.42 -0.32 -0.22 -0.28 -0.11 -0.17 -0.17
Estimated EPS -0.27 -0.22 -0.13 -0.16 -0.13 -0.14 -0.20 -0.19 -0.24 -0.32 -0.46 -0.71 -0.67 -0.72 -0.70 -0.60 -0.67 0.61 -0.51 -0.78 -0.68 -0.62 -0.67 -0.55 -0.49 -0.41 -0.31 -0.36 - - - - - -
Actual Revenue 19.52 20.9 26.5 18.46 22.8 19.93 23.36 20.45 20.75 20.25 31.45 12.54 10.8 10.49 9.6 8.96 10.95 5.38 20.75 - - - - - - - - - - - - - - -
Estimated Revenue 21.02 18.61 22.48 26.87 23.02 22.22 23.26 20.93 20.35 15.7 20.06 12.01 11.23 10.9 10.77 10.89 10.95 9.43 21.97 - - - - - - - - - - - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program